Quest Gains New York Approval for Haystack MRD Cancer Monitoring Test
The approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Category: Cancer
Cancer
Latest
Cancer
Latest
Myriad Genetics Launches Prostate Cancer Test Combining Genomics and AI
The test combines genomic risk assessment and digital pathology analysis to help clinicians tailor monitoring strategies.
Cancer
Latest
Urine Test Reduced Unnecessary Prostate Biopsies by 64%, Study Finds
Researchers reported that the test reduced unnecessary biopsies by up to 64% without compromising detection of aggressive prostate cancers.
Multi-Cancer Blood Test Reduces Stage IV Diagnoses in Large Clinical Trial
Results from the NHS-Galleri study show a 26% reduction in metastatic cancer diagnoses by the third round of screening.
Read More
FDA Approves Tissue-Based Companion Diagnostic for PIK3CA-Mutated Breast Cancer
The diagnostic test identifies specific genetic mutations to help select patients for a targeted therapy combination.
Read More
Foundation Medicine Launches MRD Test Combining Structural Variants and Digital PCR
The test uses a new approach to identify signs of cancer recurrence with faster result times for healthcare providers and patients.
Read More
Personalis Data Highlights Early Cancer Recurrence Detection
Clinical results show high sensitivity for colorectal cancer relapse and ultra-low detection limits for lung cancer.
Read More
FDA Approves New Companion Diagnostics for Prostate Cancer Treatment
The tissue- and blood-based tests identify patients with specific gene mutations who may benefit from a combination therapy.
Read More
Large Study Shows Multi-Cancer Early Detection Test Increases Cancer Detection
Results from the PATHFINDER 2 trial show the Galleri test identifies 6.5 times more cancers when used with standard screenings.
Read More
DELFI Diagnostics Receives New York State Approval for Lung Cancer Blood Test
The authorization from the New York State Department of Health makes the screening test available in all 50 states.
Read More
Labcorp Collaborates on Trial to Expand Colorectal Cancer Genetic Testing
The multicenter study will evaluate proactive outreach to at-risk relatives and the impact of multigene panel testing on patient care.
Read More
New Biomarker May Improve Diagnosis of Rare Brain and Eye Cancers
The study identifies HAVCR1 as a tool for earlier detection and treatment monitoring for primary central nervous system lymphoma.
Read More
Roche Launches Algorithm Suite for Chronic Liver Disease Management
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
Read More
ClearNote Health Raises $52 Million for Early Cancer Detection Tests
The funding will support commercial expansion of the company’s blood-based diagnostic tests and the appointment of a new president and chief operating officer.
Read More
ACS Updates Colorectal Cancer Screening Guidelines to Include Blood-Based and Stool Tests
The new recommendations add blood-based testing and multi-target stool testing as options for average-risk adults starting at age 45.
Read More
Roche to Acquire PathAI to Expand Digital Pathology and AI Diagnostics
The $750 million deal aims to integrate AI-powered technology and image management systems into pathology laboratory workflows.
Read More
ctDNA Blood Test May Help Guide Treatment Selection for Spreading Cancer
Research presented at ESTRO 2026 suggests circulating tumor DNA can identify which patients will benefit from combined radiation and drug therapy.
Read More
FDA Approves Companion Diagnostic to Identify NSCLC Patients Eligible for Tepmetko
The tissue-based test identifies patients with MET exon 14 skipping alterations eligible for treatment with tepotinib.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- ...
- 199